Compare

CJC-1295 vs Sermorelin

Two growth-hormone-releasing peptides compared — how they differ and how a physician chooses.

Medically reviewed by Charles Kamen, MD, board-certified neurologist ·

CJC-1295 vs Sermorelin — abstract science illustration, LiveNow Longevity, Las Vegas

CJC-1295 and sermorelin are both growth-hormone-releasing hormone (GHRH) analogs: instead of adding growth hormone directly, they prompt your own pituitary gland to release it. The practical difference is how long each one acts and how it fits into a protocol.

At LiveNow Longevity, Dr. Charles Kamen, MD reviews your labs and history before either is considered. This is an educational comparison, not medical advice or a substitute for evaluation.

CJC-1295Sermorelin
ClassModified (longer-acting) GHRH analogGHRH(1–29) analog
Duration of actionExtended (the DAC form lasts days)Short — mimics natural pulsatile GH release
Often combined withA GHRP such as ipamorelinUsed alone or with a GHRP
FDA statusNot FDA-approvedPreviously FDA-approved (Geref, since discontinued); now compounded
Typical use contextFewer injections, steadier signalMore physiologic, pulse-like signal
How we decideDetermined after evaluationDetermined after evaluation

Bottom line: Both work upstream — telling your own body to release growth hormone rather than replacing it. Sermorelin gives a shorter, more pulse-like signal; CJC-1295 acts longer and is often paired with a GHRP. Neither is a one-size answer, and which (if either) fits you is a medical decision made after evaluation.

More on CJC-1295More on Sermorelin

Frequently Asked Questions

What is the difference between CJC-1295 and sermorelin?

Both are GHRH analogs that stimulate your own pituitary to release growth hormone. Sermorelin is short-acting and mimics the body’s natural pulses; CJC-1295 is modified to act longer and is often combined with a GHRP like ipamorelin. Which is appropriate is determined after evaluation.

Are CJC-1295 and sermorelin FDA-approved?

Sermorelin was previously FDA-approved as Geref, which has since been discontinued; it is now used as a compounded peptide. CJC-1295 is not FDA-approved. Both are used only under physician supervision, sourced from licensed U.S. compounding pharmacies, when medically appropriate.

Is one better than the other?

Neither is universally better. Sermorelin offers a more pulse-like, physiologic signal; CJC-1295 offers a longer-acting, steadier one with fewer injections. The right choice depends on your history, labs, and goals, determined by Dr. Kamen after evaluation.

How do I get started?

Book online or call (702) 808-2650 to schedule your evaluation in Las Vegas.

Physician-Led in Las Vegas

Which one is right for you?

That is a medical decision — and exactly what the $88 evaluation is for. Dr. Charles Kamen, MD reviews your labs, history, and goals and recommends the option that fits you.

Visit our clinic in Las Vegas

Ready to start your longevity care?

Book your $88 evaluation with Dr. Kamen today, online, by phone, or by text.

Book Your $88 Evaluation

Prefer to talk? Call (702) 808-2650 or text us to book.

Physician-led peptide therapy in Las Vegas. Visit our clinic